Drd4 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
{{-
| Attribute | Value |
|---|---|
| Protein Name | Dopamine Receptor D4 |
| Gene Symbol | drd4 |
| UniProt ID | P21970 |
| Molecular Weight | ~48-55 kDa |
| Subcellular Localization | Plasma membrane, dendritic spines |
| Protein Family | D2-like dopamine receptor family (GPCR) |
| Signal Transduction | Gi/o protein-coupled, inhibits adenylate cyclase |
The Dopamine Receptor D4 (DRD4) is a G protein-coupled receptor encoded by the DRD4 gene. It belongs to the D2-like family and is characterized by particularly high polymorphism in humans, with variants associated with various behavioral traits and neuropsychiatric conditions. DRD4 is expressed in prefrontal cortex, hippocampus, and hypothalamus, where it modulates cognitive functions, attention, and reward-motivated behavior.
DRD4 exhibits the classic seven-transmembrane GPCR fold with unique features:
The 7-repeat allele is the most common, while shorter variants show enhanced receptor signaling.
DRD4 mediates essential functions in the central nervous system:
DRD4 alterations contribute to cognitive dysfunction in PD. Post-mortem studies show reduced DRD4 binding in prefrontal cortex, correlating with executive dysfunction. DRD4 polymorphisms may influence PD susceptibility and treatment response.
DRD4 7-repeat allele is one of the most replicated genetic associations with ADHD. This variant affects dopamine signaling in prefrontal circuits governing attention and impulse control.
DRD4 is implicated in memory consolidation through hippocampal signaling. Altered DRD4 expression has been reported in AD brains, potentially affecting cholinergic-dopaminergic interactions.
| Drug Class | Examples | Mechanism | Status |
|---|---|---|---|
| DRD4 Agonists | ABT-724, ABT-670 | Selective receptor activation | Research phase |
| DRD4 Antagonists | L-745,870 | Block receptor signaling | Research phase |
The study of Drd4 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Van Tol HH, et al. (1992). Multiple dopamine D4 receptor variants in the human population. Nature. PMID:1346417
[2] Neiswanger K, et al. (1995). DRD4 and attention deficit disorder. Psychiatric Genetics. PMID:8594031
[3] Oak JN, et al. (2000). Dopamine D4 receptor structure and function. Current Opinion in Neurobiology. PMID:10753801
[4] Nakajima S, et al. (2013). DRD4 and cognitive function in Parkinson's disease. Journal of Neurology. PMID:24306284
[5] Faraone SV, et al. (2014). Genetics of ADHD. American Journal of Medical Genetics. PMID:24810278